###begin article-title 0
###xml 142 146 <span type="species:ncbi:10090">Mice</span>
Anti-dsDNA Antibodies Promote Initiation, and Acquired Loss of Renal Dnase1 Promotes Progression of Lupus Nephritis in Autoimmune (NZBxNZW)F1 Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: AH CF ESM OPR. Performed the experiments: KAF SF AH NS. Analyzed the data: KAF SF AH NS CF ESM OPR. Contributed reagents/materials/analysis tools: KAF SF NS CF ESM OPR. Wrote the paper: KAF SF AH NS CF ESM OPR.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Lupus nephritis is characterized by deposition of chromatin fragment-IgG complexes in the mesangial matrix and glomerular basement membranes (GBM). The latter defines end-stage disease.
###end p 3
###begin title 4
Methodology/Principals
###end title 4
###begin p 5
###xml 178 184 <span type="species:ncbi:10090">murine</span>
In the present study we determined the impact of antibodies to dsDNA, renal Dnase1 and matrix metalloprotease (MMP) mRNA levels and enzyme activities on early and late events in murine lupus nephritis. The major focus was to analyse if these factors were interrelated, and if changes in their expression explain basic processes accounting for lupus nephritis.
###end p 5
###begin title 6
Findings
###end title 6
###begin p 7
Early phases of nephritis were associated with chromatin-IgG complex deposition in the mesangial matrix. A striking observation was that this event correlated with appearance of anti-dsDNA antibodies and mild or clinically silent nephritis. These events preceded down-regulation of renal Dnase1. Later, renal Dnase1 mRNA level and enzyme activity were reduced, while MMP2 mRNA level and enzyme activity increased. Reduced levels of renal Dnase1 were associated in time with deficient fragmentation of chromatin from dead cells. Large fragments were retained and accumulated in GBM. Also, since chromatin fragments are prone to stimulate Toll-like receptors in e.g. dendritic cells, this may in fact explain increased expression of MMPs.
###end p 7
###begin title 8
Significance
###end title 8
###begin p 9
These scenarios may explain the basis for deposition of chromatin-IgG complexes in glomeruli in early and late stages of nephritis, loss of glomerular integrity and finally renal failure.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 211 214 211 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Tan1">[1]</xref>
A wide spectrum of autoimmune responses and organ manifestations are characteristic of Systemic lupus erythematosus (SLE), and are used by the American College of Rheumatology (ACR) as criteria to classify SLE. [1] Of particular importance in context of the present study are criteria linked to development of kidney disease: Production of potentially pathogenic anti-dsDNA antibodies (criterion # 10) and deposition of chromatin-containing immune complexes in kidneys (criterion # 7).
###end p 11
###begin p 12
###xml 514 517 514 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Qureshi1">[2]</xref>
###xml 518 521 518 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Amital1">[4]</xref>
###xml 537 540 533 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Mostoslavsky1">[5]</xref>
###xml 541 544 537 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Mason1">[7]</xref>
###xml 593 596 589 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Chan1">[8]</xref>
###xml 598 601 594 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Chen1">[9]</xref>
Over time, different concepts have been discussed to describe possible basic processes linked to initiation of lupus nephritis, and to progression of mild into end-stage organ disease. There is a consensus stating that anti-dsDNA and anti-chromatin antibodies are central in initiation and maintenance of lupus nephritis, but there is no agreement as to how they interact with glomerular structures. This could be due to cross-reaction of anti-chromatin antibodies with inherent glomerular structures like laminin [2]-[4], alpha-actinin [5]-[7], or with membrane components of mesangial cells [8], [9], or to binding of anti-chromatin antibodies to chromatin fragments exposed in affected glomeruli. Recent data favour the latter model.
###end p 12
###begin p 13
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Mjelle1">[10]</xref>
###xml 448 452 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Mjelle1">[10]</xref>
###xml 454 458 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Kalaaji1">[11]</xref>
###xml 628 632 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Kalaaji2">[12]</xref>
###xml 634 638 634 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Mjelle1">[10]</xref>
###xml 649 653 649 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Kalaaji1">[11]</xref>
###xml 796 800 796 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Kalaaji3">[13]</xref>
###xml 621 627 <span type="species:ncbi:10090">murine</span>
###xml 643 648 <span type="species:ncbi:9606">human</span>
We have demonstrated that chromatin fragments possess a high intrinsic affinity for glomerular membrane and matrix components like laminins and collagen IV [10]. These fragments are observed as electron dense structures (EDS) along glomerular basement membranes (GBM) and in the mesangial matrix. Glomerular EDS are terminal deoxynucleotidyl transferase-mediated dUTP nick end-labelling (TUNEL) positive, demonstrating that they contain nicked DNA [10], [11]. Furthermore, antibodies to components of chromatin, like those reactive with DNA, histones or transcription factors, bind in vitro to antigens present in EDS in murine [12], [10] and human [11] forms of lupus nephritis. Binding of antibodies in vivo to other structures that are not parts of EDS have not been observed in these studies [13].
###end p 13
###begin p 14
###xml 337 343 337 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dnase1</italic>
###xml 416 420 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Zykova1">[14]</xref>
###xml 422 426 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Seredkina1">[15]</xref>
###xml 495 499 495 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Basnakian1">[16]</xref>
###xml 974 978 974 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Krieg1">[17]</xref>
###xml 979 983 979 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Lim1">[23]</xref>
###xml 1155 1159 1155 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Daikh1">[24]</xref>
###xml 1161 1165 1161 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Roth1">[25]</xref>
###xml 1329 1333 1329 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Merrell1">[22]</xref>
###xml 1335 1339 1335 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Lim1">[23]</xref>
###xml 1444 1448 1444 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Overall1">[26]</xref>
###xml 1450 1454 1450 1454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Overall2">[27]</xref>
###xml 1694 1698 1694 1698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Tveita1">[28]</xref>
###xml 1689 1693 <span type="species:ncbi:10090">mice</span>
It is not clear why chromatin fragments are exposed in kidneys, but this phenomenon may be linked to reduced ability of renal nucleases to degrade apoptotic or necrotic chromatin within the kidneys. We have recently demonstrated that reduced fragmentation of chromatin during evolution of nephritis concur with an acquired loss of renal Dnase1 mRNA at the time when nephritis transforms into end-stage organ disease [14], [15]. Dnase1 accounts for more than 80% of total renal nuclease activity [16]. With low renal Dnase1 enzyme activity, apoptotic chromatin may not be appropriately fragmented and may instead be transformed into secondary necrotic chromatin fragments released from apoptotic blebs. Secondary to this event, chromatin fragments are exposed to the environment within kidneys, and bind glomerular membranes. Chromatin fragments may also be taken up by macrophages and dendritic cells in which they stimulate TLRs through CpG (TLR9) or RNA (TLR7) structures [17]-[23]. Engagement of TLRs may serve two functions: Up-regulation of co-stimulatory molecules (CD80/CD86) which are important for activation of chromatin-specific T helper cells [24], [25], required to transform chromatin-specific B cells into anti-chromatin antibody-secreting plasma cells; and up-regulation of certain matrix metalloproteases (MMPs) [22], [23]. Secreted MMPs have the potential to disintegrate GBM and the mesangial matrix by enzymatic degradation [26], [27]. This may facilitate deposition of chromatin fragment-IgG complexes in GBM. In harmony with this assumption, MMP2 and MMP9 activities are reported to be increased within glomeruli of nephritic, but not pre-nephritic, (NZBxNZW)F1 (BW) mice [28].
###end p 14
###begin p 15
From data in these referenced studies, we predict that loss of renal Dnase1 correlates with exposure of large chromatin fragments within glomeruli and with increased MMP activities in the kidneys. The present study was designed to analyse how regulation of Dnase1, MMP2 and MMP9 mRNA levels and enzyme activities correlate with each other, with production of antibodies to dsDNA, with successive deposition of EDS in the mesangial matrix and in GBM, and finally with progressive proteinuria characteristic of lupus nephritis. The data presented here may explain the molecular and genetical basis for deposition of chromatin-IgG complexes in glomeruli in early and late stages of nephritis, with loss of glomerular integrity and renal failure as the final outcome.
###end p 15
###begin title 16
Results
###end title 16
###begin title 17
###xml 117 121 <span type="species:ncbi:10090">Mice</span>
###xml 129 133 <span type="species:ncbi:10090">Mice</span>
Dnase1, MMP2 and MMP9 mRNA Levels and Corresponding Enzyme Activities, and Degree of Proteinuria in Pre-Nephritic BW Mice and in Mice with EDS in the Mesangial Matrix or in GBM
###end title 17
###begin p 18
###xml 374 383 374 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g001">Figure 1A</xref>
###xml 443 452 443 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g001">Figure 1B</xref>
###xml 536 545 536 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g001">Figure 1C</xref>
###xml 638 646 638 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008474.s001">Table S1</xref>
###xml 880 889 880 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g002">Figures 2</xref>
###xml 891 897 891 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g004">4B, 4C</xref>
###xml 899 905 899 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g005">5A, 5B</xref>
###xml 910 911 910 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g006">6</xref>
###xml 1018 1022 1018 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Kalaaji2">[12]</xref>
###xml 3 7 <span type="species:ncbi:10090">mice</span>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
###xml 386 390 <span type="species:ncbi:10090">mice</span>
###xml 458 462 <span type="species:ncbi:10090">mice</span>
###xml 562 566 <span type="species:ncbi:10090">mice</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
###xml 687 691 <span type="species:ncbi:10090">mice</span>
###xml 768 772 <span type="species:ncbi:10090">mice</span>
###xml 987 991 <span type="species:ncbi:10090">mice</span>
BW mice were sacrificed approximately every second week (in sets of 3) until development of end-stage lupus-like nephritis, and were analyzed for renal Dnase1, MMP2 and MMP9 mRNA levels and for corresponding enzyme activities. The mice were initially divided into 3 groups according to kidney morphology; pre-nephritic mice (Group 1, no glomerular deposits of EDS (n = 27), Figure 1A), mice with mesangial EDS deposits only (Group 2 (n = 17), Figure 1B), or mice with EDS deposits in both mesangial matrix and in GBM (Group 3 (n = 10), Figure 1C). The number of mice in these groups refers to mice with complete sets of data (n = 54, see Table S1 for complete sets of data in individual mice identifiable by labels). In analyses of individual parameters, 2 additional mice with relevant data are included. These were not analyzed for glomerular EDS deposits and are excluded from Figures 2, 4B, 4C, 5A, 5B and 6. No glomerular deposits of EDS were observed in sex and age matched BALB/c mice (data not shown, see also [12]).
###end p 18
###begin title 19
###xml 12 16 <span type="species:ncbi:10090">mice</span>
(NZBxNZW)F1 mice grouped according to glomerular location of EDS deposits.
###end title 19
###begin p 20
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
(NZBxNZW)F1 mice were sacrificed approximately every second week (in sets of 3) until development of end-stage lupus-like nephritis. The mice were sorted into 3 main groups according to kidney morphology; pre-nephritic mice (Group 1, no glomerular deposits of EDS (n = 27), A), mice with mesangial EDS deposits (Group 2 (n = 17), B), or mice with EDS deposits in GBM (Group 3 (n = 10), C). Magnificationx40 k.
###end p 20
###begin title 21
###xml 115 119 <span type="species:ncbi:10090">mice</span>
Levels of Dnase1, MMP2 and MMP9 mRNA and enzyme activities, and mean anti-dsDNA antibody titers in Group 1-Group 3 mice.
###end title 21
###begin p 22
###xml 529 533 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Tveita2">[29]</xref>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 334 338 <span type="species:ncbi:10090">mice</span>
###xml 464 468 <span type="species:ncbi:10090">mice</span>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
###xml 726 730 <span type="species:ncbi:10090">mice</span>
There were no significant differences with respect to Dnase1, MMP2 or MMP9 mRNA levels and degree of proteinuria between Group 1 and Group 2 mice (A). In Group 3 mice, Dnase1 mRNA levels were severely and significantly down-regulated, while MMP2 mRNA levels and proteinuria were significantly higher than in the former 2 groups of BW mice (A). The variations in mRNA levels were reflected in a similar variation in enzyme activities, as demonstrated in individual mice by relevant zymography analyses (exemplified in B, see also [29]). The results in A and B indicate that low Dnase1, high MMP2 and severe proteinuria may be interdependent parameters. Mean anti-dsDNA antibody titers were lower in Group 3 mice, compared with mice in Group 2, although the difference was not statistically significant (C). Arrows in A and B point at reduced Dnase1 mRNA levels. Results are given as mean (+/-SD) and an unpaired t test was performed to determine differences between each group for each parameter. A one-way ANOVA was performed to compare all groups for each parameter. n.s.: not significant.
###end p 22
###begin p 23
###xml 19 28 19 28 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g002">Figure 2A</xref>
###xml 487 496 487 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g002">Figure 2A</xref>
###xml 611 620 611 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g002">Figure 2A</xref>
###xml 800 809 800 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g002">Figure 2B</xref>
###xml 820 824 820 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Tveita2">[29]</xref>
###xml 919 927 919 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008474.s001">Table S1</xref>
###xml 950 959 950 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008474.s002">Figure S1</xref>
###xml 1283 1291 1283 1291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008474.s001">Table S1</xref>
###xml 1296 1305 1296 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008474.s002">Figure S1</xref>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
###xml 596 600 <span type="species:ncbi:10090">mice</span>
###xml 1016 1020 <span type="species:ncbi:10090">mice</span>
As demonstrated in Figure 2A, there were no significant differences between Dnase1, MMP2 or MMP9 mRNA levels in mice from Group 1 and Group 2. In Group 3 mice, however, Dnase1 mRNA levels were severely down-regulated compared with mice in Group 1 (p = 0.0001) and Group 2 (p = 0.024). MMP2 mRNA levels were higher in Group 3 compared with Group 1 (p = 0.009) and Group 2 (p = 0.043) mice, while there were no statistically significant differences in MMP9 mRNA levels between the groups (Figure 2A). In Group 3 mice, proteinuria was significantly more pronounced than in the former 2 groups of BW mice (p<0,001, Figure 2A). The variations in Dnase1, MMP2, and MMP9 mRNA levels were reflected in a similar variation in enzyme activities, as demonstrated by relevant zymography analyses (exemplified in Figure 2B, see also [29]). For more extended analyses of mRNA levels and their correlation with enzyme activities, see Table S1 (for mRNA levels) and Figure S1 (for zymographic Dnase1 enzyme activities in individual mice). These results indicate that low Dnase1 activity, high MMP2 activity, and severe proteinuria are interdependent parameters involved in development of end-stage kidney disease. Since mRNA levels are given as exact figures, and correlate with zymography results (Table S1 and Figure S1), which, however, are not given as exact measures, data in the next sections are given as fold change in Dnase1 and MMP mRNA levels.
###end p 23
###begin p 24
###xml 123 132 123 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g002">Figure 2C</xref>
###xml 305 314 305 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008474.s002">Figure S1</xref>
###xml 456 460 456 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Zykova1">[14]</xref>
###xml 462 466 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Seredkina1">[15]</xref>
###xml 468 472 468 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Tveita2">[29]</xref>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 484 488 <span type="species:ncbi:10090">mice</span>
Although not statistically significant, mean anti-dsDNA antibody titers were lower in Group 3, compared with Group 2 mice (Figure 2C). In sex and age matched BALB/c mice, Dnase1, MMP2 and MMP9 mRNA levels and enzyme activities were present at normal and stable values throughout the observation time (See Figure S1 for Dnase1 zymography using proteins extracted from BALB/c kidneys). This has also been demonstrated in a series of descriptive observations [14], [15], [29]. All these mice were negative for anti-dsDNA antibodies (data not shown).
###end p 24
###begin title 25
Loss of Renal Dnase1 mRNA Correlates with Increased Renal MMP2 mRNA Levels
###end title 25
###begin p 26
###xml 115 124 115 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g003">Figure 3A</xref>
###xml 250 266 250 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g003">Figure 3B and 3C</xref>
###xml 574 583 574 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g003">Figure 3D</xref>
###xml 658 665 658 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008474-t001">Table 1</xref>
###xml 811 820 811 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g002">Figure 2B</xref>
###xml 825 833 825 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008474.s001">Table S1</xref>
###xml 838 847 838 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008474.s002">Figure S1</xref>
###xml 1114 1123 1114 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g003">Figure 3D</xref>
###xml 1125 1132 1125 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008474-t001">Table 1</xref>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 471 476 <span type="species:ncbi:10090">mouse</span>
Dnase1 mRNA levels varied considerably in mice analyzed at various time points over the entire observation period (Figure 3A). Similarly, both MMP2 and MMP9 mRNA levels showed a substantial variability with some peaks generally in mice of older age (Figure 3B and 3C, for MMP2 and MMP9 mRNA, respectively). Since nephritis does not appear at the same age in individual BW mice, instead of relating data to age, levels of Dnase1, MMP2 and MMP9 mRNA were combined for each mouse, and this set of data was sorted by descending Dnase1 mRNA levels. As is clearly demonstrated in Figure 3D, very low levels of Dnase1 correlated inversely with high levels of MMP2 (Table 1, correlation coefficient = -0,299, p = 0.016). This was also demonstrated by a similar inverse correlation of Dnase1 and MMP2 enzyme activities (Figure 2B and Table S1 and Figure S1, which demonstrates that mRNA levels largely reflected enzyme activities). This indicates that there may be a causal relationship between loss of Dnase1 and up-regulation of MMP2 (see below). There was no significant correlation between Dnase1 and MMP9 mRNA levels (Figure 3D, Table 1).
###end p 26
###begin title 27
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Dnase1, MMP2 and MMP9 mRNA levels and their correlations in mice of different age.
###end title 27
###begin p 28
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 325 330 <span type="species:ncbi:10090">mouse</span>
Dnase1 mRNA levels fluctuated over the entire observation time (A). Similarly, both MMP2 and MMP9 showed a considerable variability with some peaks in mice of higher age (B and C, for MMP2 and MMP9, respectively). To analyse if levels of Dnase1, MMP2 and MMP9 mRNA correlated with each other, the data were combined for each mouse, and this set of data was sorted by descending Dnase1 mRNA levels. As demonstrated in panel D, very low levels of Dnase1 were inversely correlated with high levels of MMP2 (correlation coefficient -0,299, p = 0,016). This indicates that there is a link between loss of Dnase1 and up-regulation of MMP2. Chromatin fragments that are not appropriately fragmented and cleared may be the common denominator (see text for details).
###end p 28
###begin title 29
###xml 80 81 80 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt101">1</xref>
Statistical analyses of the parameters analyzed: Correlations and significances.1
###end title 29
###begin p 30
Upper diagonal part contains correlation coefficient estimates, lower diagonal part (in bold) contains corresponding p-values.
###end p 30
###begin p 31
EDS: electron dence structures.
###end p 31
###begin p 32
MM: mesangial matrix.
###end p 32
###begin p 33
GBM: glomerular basement membranes.
###end p 33
###begin p 34
abs: antibodies.
###end p 34
###begin p 35
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
Correlation and corresponding p-values for EDS in mesangial matrix are calculated from mice with no glomerular EDS, or EDS in the mesangial matrix only. In these calculations, we excluded mice with EDS in GBM, since all these have mesangial matrix deposits, while the biological consequences of EDS in GBM overrule those of EDS in the mesangial matrix (see text).
###end p 35
###begin title 36
Proteinuria Is Not Related to Serum Anti-dsDNA Antibody Titers, but Correlates with EDS in the GBM, and Inversely with Renal Dnase1 mRNA Levels
###end title 36
###begin p 37
###xml 223 230 223 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008474-t001">Table 1</xref>
###xml 410 419 410 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g004">Figure 4A</xref>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
In order to examine the impact of anti-dsDNA antibodies on development of proteinuria, we analyzed if the presence of anti-dsDNA antibodies correlated with proteinuria. These parameters correlated with each other (p<0,001, Table 1), while titers of the antibodies were not associated with degree of proteinuria as high antibody titers appeared in individual mice with low degree of proteinuria and vice versa (Figure 4A).
###end p 37
###begin title 38
Severe proteinuria correlates with EDS deposits in GBM, and inversely with renal Dnase1 mRNA levels.
###end title 38
###begin p 39
###xml 927 935 921 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g002">Figure 2</xref>
###xml 1167 1174 1159 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008474-t001">Table 1</xref>
###xml 3 7 <span type="species:ncbi:10090">mice</span>
###xml 392 397 <span type="species:ncbi:10090">mouse</span>
###xml 497 502 <span type="species:ncbi:10090">mouse</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
###xml 947 951 <span type="species:ncbi:10090">mice</span>
###xml 1037 1042 <span type="species:ncbi:10090">mouse</span>
###xml 1141 1145 <span type="species:ncbi:10090">mice</span>
In mice sorted for age, there was no association between degree of proteinuria and levels of anti-dsDNA antibody titers (A). To analyse if location of EDS deposits had impact on proteinuria, data on proteinuria and deposition of EDS in the mesangial matrix (weighted 1 in B) or in the GBM (weighted 2 to make a visual distinction from deposits in the mesangial matrix) were combined for each mouse, and sorted by ascending values of proteinuria. Severe proteinuria (>/=20 g/L) was, except for one mouse with intermediate proteinuria (</=3 g/L), exclusively observed in mice with EDS in GBM (B), while intermediate or mild proteinuria was observed in only 4 out of 17 mice with mesangial matrix deposits (B). In panel C, degree of proteinuria and renal Dnase1 mRNA levels were paired and sorted by ascending proteinuria. Severe proteinuria (>/=20 g/L) correlated with a substantial loss of Dnase1 mRNA (and enzyme activity, see Figure 2). Thus, in mice selected for proteinuria >/=20 g/L, renal Dnase1 mRNA was nearby lost in all but one mouse (C), and deposits of chromatin-IgG complexes (observed as EDS) in GBM were observed only in these mice. For statistics, see Table 1.
###end p 39
###begin p 40
###xml 99 108 99 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g004">Figure 4B</xref>
###xml 321 330 321 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g004">Figure 4B</xref>
###xml 684 691 682 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008474-t001">Table 1</xref>
###xml 246 251 <span type="species:ncbi:10090">mouse</span>
###xml 393 398 <span type="species:ncbi:10090">mouse</span>
###xml 424 428 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 616 620 <span type="species:ncbi:10090">mice</span>
###xml 674 678 <span type="species:ncbi:10090">mice</span>
###xml 976 980 <span type="species:ncbi:10090">mice</span>
Next, data on proteinuria and deposition of EDS in either the mesangial matrix only (weighted 1 in Figure 4B) or also in the GBM (weighted 2 to make a visual distinction from deposits in the mesangial matrix in the figure) were combined for each mouse, and the paired data were sorted by ascending values of proteinuria. Figure 4B shows that severe proteinuria (>/=20 g/L) was, except for one mouse, exclusively observed in mice with EDS in GBM, while intermediate or low levels of proteinuria was observed in 4 out of the 17 mice with mesangial matrix deposits only, which is a significantly higher number than for mice without any EDS deposition in glomeruli (0 out of 27 mice, see Table 1 for statistics). The data also demonstrate that deposition of chromatin fragment-IgG complexes in the mesangial matrix may not necessarily result in clinical nephritis. EDS deposits in the mesangial matrix may, therefore, be compatible with a silent organ manifestation in individual mice.
###end p 40
###begin p 41
###xml 526 535 526 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g004">Figure 4C</xref>
###xml 546 553 546 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008474-t001">Table 1</xref>
###xml 676 685 674 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g004">Figure 4C</xref>
###xml 828 837 826 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g004">Figure 4B</xref>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 669 674 <span type="species:ncbi:10090">mouse</span>
###xml 781 785 <span type="species:ncbi:10090">mice</span>
To further investigate the hypothesis that chromatin fragment deposition, especially in the GBM, depends on loss of renal Dnase1, we assessed whether severe proteinuria indeed correlated inversely with Dnase1 mRNA levels and Dnase1 activity the same way as severe proteinuria correlated with EDS in GBM. When proteinuria and Dnase1 mRNA levels were combined in individual mice, and the two parameters sorted by ascending proteinuria, it became evident that severe proteinuria correlated with critically down-regulated Dnase1 (Figure 4C, p<0.001, Table 1). Thus, in mice selected on the basis of proteinuria >/=20 g/L, renal Dnase1 mRNA was nearly absent in all but one mouse (Figure 4C), and deposits of chromatin-IgG complexes (observed as EDS) in GBM were observed only in these mice except for one with proteinuria of 3 g/L (Figure 4B).
###end p 41
###begin title 42
Presence of Anti-dsDNA Antibodies and Low Renal Dnase1 mRNA Level and Corresponding Enzyme Activity Correlate with the Deposition of EDS in the Mesangial Matrix and in the GBM, Respectively
###end title 42
###begin p 43
###xml 35 43 35 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g004">Figure 4</xref>
###xml 396 411 396 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g005">Figure 5A and B</xref>
###xml 541 550 541 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g005">Figure 5A</xref>
###xml 738 747 738 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g002">Figure 2B</xref>
###xml 752 761 752 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008474.s002">Figure S1</xref>
###xml 942 949 942 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008474-t001">Table 1</xref>
###xml 1024 1033 1024 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g005">Figure 5A</xref>
###xml 1046 1053 1046 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008474-t001">Table 1</xref>
According to the data presented in Figure 4, which demonstrate that severe proteinuria is inversely correlated with Dnase1 mRNA levels and enzyme activities, and positively with EDS in GBM, it was important to analyse whether low Dnase1 mRNA levels also correlated with EDS deposition in the mesangial matrix, or only in GBM. Data on Dnase1 mRNA levels and EDS in mesangial matrix (weighted 1 in Figure 5A and B), or in GBM (weighted 2) where combined and sorted by descending Dnase1 mRNA levels. The result of this analysis is presented in Figure 5A, and demonstrates a clear correlation between low Dnase1 mRNA levels and the presence of EDS in GBM. Loss of Dnase1 mRNA is also reflected by a corresponding loss of enzyme activity (see Figure 2B and Figure S1 for representative examples). The association of low Dnase1 mRNA levels and presence of EDS in GBM was statistically highly significant (correlation coefficient = -0,565, p<0,001, Table 1). EDS in the mesangial matrix was not associated with Dnase1 mRNA levels (Figure 5A, p = 0,740, Table 1)). The latter deposits are, therefore, most likely generated by a mechanism independent from renal Dnase1 activity.
###end p 43
###begin title 44
Anti-dsDNA antibodies and renal Dnase1 levels, and their correlation with EDS in mesangial matrix and GBM, respectively.
###end title 44
###begin p 45
###xml 74 89 74 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g005">Figure 5A and B</xref>
###xml 377 384 377 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008474-t001">Table 1</xref>
###xml 550 557 550 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008474-t001">Table 1</xref>
###xml 685 692 685 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008474-t001">Table 1</xref>
###xml 1088 1095 1088 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008474-t001">Table 1</xref>
###xml 139 144 <span type="species:ncbi:10090">mouse</span>
Data on Dnase1 mRNA levels and EDS in the mesangial matrix (weighted 1 in Figure 5A and B), or in GBM (weighted 2) where combined for each mouse and sorted by descending Dnase1 mRNA levels. The result of this analysis demonstrates a clear negative correlation between Dnase1 mRNA levels and presence of EDS in GBM. This association was statistically highly significant (A, see Table 1 for statistical analyses). The inverse correlation of EDS in the mesangial matrix with Dnase1 mRNA levels was weaker, and did not reach statistical significance (A, Table 1). The presence of EDS solely in the mesangial matrix was significantly associated with production of anti-dsDNA antibodies (B, Table 1). This demonstrates that deposition of EDS in the mesangial matrix and in the GBM may originate from different molecular processes; EDS in mesangial matrix depend on presence of antibodies to dsDNA, while EDS in GBM depend on reduced renal Dnase1 activity. Production and titers of antibodies to dsDNA was not significantly associated with levels of renal. Dnase1 mRNA and enzyme activities (C, Table 1).
###end p 45
###begin p 46
###xml 124 133 124 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g005">Figure 5B</xref>
###xml 177 184 177 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008474-t001">Table 1</xref>
###xml 585 594 585 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g005">Figure 5C</xref>
###xml 607 614 607 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008474-t001">Table 1</xref>
The presence of EDS solely in the mesangial matrix was significantly associated with the presence of anti-dsDNA antibodies (Figure 5B, correlation coefficient = 0,899, p<0,001, Table 1). This demonstrates that deposits of EDS in the mesangial matrix and in the GBM have different origins; EDS in the mesangial matrix may depend on the presence of antibodies to dsDNA, while deposition of EDS in GBM may be a consequence of reduced renal Dnase1 activity. On the other hand, production of antibodies to dsDNA did not correlate with the levels of renal Dnase1 mRNA and enzyme activities (Figure 5C, p = 0,124, Table 1).
###end p 46
###begin title 47
Overall Statistical Analyses
###end title 47
###begin p 48
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008474-t001">Table 1</xref>
###xml 194 202 194 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g006">Figure 6</xref>
###xml 717 725 717 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g006">Figure 6</xref>
###xml 888 897 888 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008474.s003">Figure S2</xref>
###xml 930 938 930 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g006">Figure 6</xref>
###xml 1020 1028 1020 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g001">Figure 1</xref>
###xml 1033 1041 1033 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g002">Figure 2</xref>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
###xml 731 735 <span type="species:ncbi:10090">mice</span>
###xml 922 926 <span type="species:ncbi:10090">mice</span>
###xml 1009 1013 <span type="species:ncbi:10090">mice</span>
Table 1 shows a square matrix where the upper diagonal part demonstrates correlation coefficients, and the lower diagonal part the corresponding p-values of the data generated in this study. In Figure 6, the result of a principal component analysis (PCA) biplot drawn with the R biplot function is demonstrated. The PCA biplot is aimed to optimally display variances and not correlations. The angles between the various biplot axes are good indicators of the correlations among the variables (shown as arrows). The position of the samples of individual mice (shown as plus signs) relative to the arrows provides good indications as to which variable(s) have had the largest effect. As is evident in data presented in Figure 6, the mice confine perfectly into three groups, one pre-nephritic, one with mild mesangial nephritis, and one with end-stage membrano-proliferative nephritis (see Figure S2 to identify the grouped mice in Figure 6 by labels). This result confirms that the parameters used to group BW mice as in Figure 1 and Figure 2 are biologically relevant.
###end p 48
###begin title 49
A principal component analysis (PCA) of parameters included in this study.
###end title 49
###begin p 50
###xml 523 531 523 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g001">Figure 1</xref>
###xml 536 544 536 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g002">Figure 2</xref>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 504 508 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
###xml 718 723 <span type="species:ncbi:10090">mouse</span>
This PCA biplot aims to optimally display variances and not correlations. The angles between the various biplot axes serve as good indicators of the correlations among the variables (shown as arrows). Similarly, the position of the samples of individual mice (shown as plus signs) relative to the arrows, provide good indications as to which variable(s) have had the largest effect. The result of the biplot demonstrates that groups emerging from this analysis perfectly correlated with the groups of BW mice as defined in Figure 1 and Figure 2, defined as pre-nephritic BW mice (Group 1), BW mice with deposits of EDS in the mesangial matrix (Group 2) or with deposits in the GBM (Group 3). The circle identifies the mouse with the lowest renal Dnase1 mRNA level and enzyme activity, and the highest MMP2 and MMP9 mRNA levels and enzyme activities and with proteinuria >/=20 g/L.
###end p 50
###begin title 51
Discussion
###end title 51
###begin p 52
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Mortensen1">[30]</xref>
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Mortensen2">[31]</xref>
###xml 691 695 691 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Mortensen1">[30]</xref>
###xml 697 701 697 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Mortensen2">[31]</xref>
###xml 738 742 738 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Haugbro1">[32]</xref>
The basic hypothesis motivating the present study was that clinical lupus nephritis is a distinct organ disease with an aetiology linked to an acquired loss of renal Dnase1 enzyme activity. Acquired deficiency of renal Dnase1 activity is assumed to promote a progressive exposure of secondary necrotic chromatin in GBM, and a consequent development of severe nephritis [30], [31]. This may, however, be restricted to individuals with anti-chromatin antibodies. In the absence of anti-chromatin antibodies, exposed chromatin may be more or less harmless. Similarly, antibodies in the absence of exposed chromatin may render them apathogenic. This latter statement relates to their pathogenic [30], [31], but not to their diagnostic impact [32]. The lupus nephritis phenotype is, therefore, characterized by glomerular binding of complexes of chromatin fragments and anti-chromatin antibodies.
###end p 52
###begin p 53
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Zykova1">[14]</xref>
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Tveita1">[28]</xref>
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Tveita2">[29]</xref>
###xml 292 296 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Overall1">[26]</xref>
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Overall2">[27]</xref>
Data so far demonstrate that accumulation of chromatin fragment-IgG complexes correlates with a progressive loss of renal Dnase1 enzyme activity [14] and with increased renal MMP2 and, to a lesser extent, MMP9 activities [28], [29]. MMPs may disrupt and disintegrate mesangial matrix and GBM [26], [27]. These two events explain why large chromatin fragments generated within the kidneys finally get access to GBM. Therefore, loss of Dnase1 and increased MMP activities are identified as factors that may contribute to transformation of mild mesangial into severe membrano-proliferative lupus nephritis.
###end p 53
###begin p 54
###xml 297 301 <span type="species:ncbi:10090">mice</span>
###xml 619 623 <span type="species:ncbi:10090">mice</span>
In this study we analyzed if loss of renal Dnase1 correlated with increased MMP activity in the kidneys, and with exposure of large chromatin fragments at loci typical for lupus nephritis-namely in the mesangial matrix and in the GBM. A series of baseline data were collected in groups (n = 3) of mice at consecutive intervals. These were combined to analyse if regulation of Dnase1, MMP2 and MMP9 mRNA levels and enzyme activities (analyzed by relevant zymography assays) correlated with the production of antibodies to dsDNA, and with the successive deposition of EDS in the mesangial matrix and in GBM in individual mice. In the end, these factors were correlated with progressive proteinuria and end-stage organ disease.
###end p 54
###begin p 55
###xml 1550 1554 1550 1554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Christensen2">[21]</xref>
###xml 1556 1560 1556 1560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Mortensen1">[30]</xref>
###xml 1562 1566 1562 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Rekvig1">[33]</xref>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 250 255 <span type="species:ncbi:10090">mouse</span>
###xml 518 522 <span type="species:ncbi:10090">mice</span>
###xml 781 785 <span type="species:ncbi:10090">mice</span>
For each parameter, it was difficult to determine correlation between e.g. Dnase1, MMP2 or MMP9 mRNA levels with age in individual mice since nephritis developed at different time points in different mice. However, by combining data obtained in each mouse, and by sorting them by parameters one by one at the time in an ascending or descending way, clear correlations became apparent. For example, a combination of the highest values for MMP2 combined with chromatin fragments accumulated in GBM were only observed in mice with the lowest renal Dnase1 mRNA levels. This indicates that these kidneys have entered the state of end-organ disease when Dnase1 mRNA and enzyme activity were at the lowest levels. Similarly, sorting data by increasing proteinuria, it became evident that mice with severe proteinuria had the lowest levels of renal Dnase1. These observations fit with the hypothesis that reduced Dnase1 mRNA level and enzyme activity result in reduced fragmentation of chromatin from dead cells. Large chromatin fragments became, instead of being cleared, retained in tissue, and exposed to infiltrating dendritic cells and macrophages. Upon interaction of chromatin with TLRs in these cells, co-stimulatory molecules (CD80/CD86) are up-regulated, while peptides from the same chromatin fragments may get processed, and presented by MHC class II molecules. This may, although not proven by data, be sufficient to activate chromatin-specific T cells with potential to transform chromatin-specific B cells into antibody-secreting plasma cells [21], [30], [33].
###end p 55
###begin p 56
###xml 496 500 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Merrell1">[22]</xref>
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Lim1">[23]</xref>
###xml 508 512 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Lim2">[34]</xref>
###xml 514 518 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Zhang1">[35]</xref>
###xml 636 640 636 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Visse1">[36]</xref>
###xml 642 646 642 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Nagase1">[37]</xref>
###xml 890 894 890 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Samejima1">[38]</xref>
###xml 896 900 896 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Napirei1">[39]</xref>
###xml 1084 1088 1084 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Tveita2">[29]</xref>
###xml 1434 1439 <span type="species:ncbi:9606">human</span>
###xml 1515 1523 <span type="species:ncbi:9606">patients</span>
###xml 1529 1534 <span type="species:ncbi:9606">human</span>
On the other hand, chromatin fragments that are not appropriately fragmented and cleared may be the factor that determines if induced anti-chromatin antibodies gain pathogenic potential. This can only happen if chromatin is exposed and thereby made available for such antibodies. One factor that can exaggerate this situation is increased secretion of MMPs, since chromatin fragments have the potential to up-regulate MMP production and secretion through activation of the TLR9 signaling pathway [22], [23], [34], [35]. This does not rule out that other mechanisms may contribute to increased production of MMPs in lupus nephritis (see [36], [37] for reviews). Persistently increased MMP activity within glomeruli may, therefore, be a result of an inflammatory process maintained by retained necrotic cellular debris linked to loss of apoptosis- and necrosis-related Dnase1 enzyme activity [38], [39]. Continuously increased matrix degradation by the MMPs may disrupt GBM integrity and thereby promote deposition of immune complexes in these structures, as discussed by Tveita et al. [29]. This process is reflected by the data presented in this study, where loss of Dnase1 correlated with increased MMP2 mRNA levels and enzyme activities in affected kidneys; with increased exposure of chromatin fragments in complex with IgG within GBM; and with severe proteinuria (>/=20 g/L). These results create the basis for similar studies in human lupus nephritis. Preliminary results from analyses of kidney biopsies from patients with human lupus nephritis demonstrate a similar relationship between severe nephritis and loss of the Dnase1 enzyme (studies in progress).
###end p 56
###begin p 57
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Amoura1">[40]</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Licht1">[42]</xref>
###xml 591 595 587 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Radeke1">[43]</xref>
Since deposition of EDS in the mesangial matrix preceded reduced renal Dnase1 levels, this less harmful process has another origin. In the data sets presented here, it is evident that deposition of EDS in the mesangial matrix correlated significantly with appearance of anti-dsDNA antibodies in sera. An explanation for this linkage may be that circulating nucleosomes [40]-[42] bind nucleosome-reactive antibodies, and re-circulate as immune complexes. These may be bound to glomerular mesangial cells through Fc regions of IgG in the complexes, since these cells express Fcgamma-receptors [43]. If the amount of immune complexes exceeds the clearance capacity of mesangial cells, this could result in release of immune complexes into the mesangial matrix surrounding these cells.
###end p 57
###begin p 58
###xml 676 680 <span type="species:ncbi:10090">mice</span>
###xml 697 702 <span type="species:ncbi:9606">human</span>
###xml 707 715 <span type="species:ncbi:9606">patients</span>
###xml 761 766 <span type="species:ncbi:9606">human</span>
###xml 776 781 <span type="species:ncbi:10090">mouse</span>
The consequent interpretation of the data presented here is that lupus nephritis is a principally two-stepped organ disease where each step has its distinct aetiology. The early phase of lupus nephritis correlates with deposition of complexes of chromatin fragments and IgG in the mesangial matrix. This process is associated with the production of anti-DNA (anti-chromatin) antibodies, and is characterized by mild or clinically silent nephritis. This process is consistent with an observed drop in serum concentration of DNA (nucleosomes) at the time when anti-dsDNA antibodies appeared in circulation, as determined by real time PCR applied to serial serum samples from BW mice or to sera from human SLE patients. This real time PCR was performed with Alu- (human) or B1- (mouse) specific primers (M Hellvik Jorgensen et al., manuscript in preparation).
###end p 58
###begin p 59
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Doerfler1">[44]</xref>
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Dai1">[45]</xref>
###xml 878 882 878 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Montesano1">[46]</xref>
###xml 884 888 884 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Chen2">[47]</xref>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
At a certain time point in the life of BW mice, the renal Dnase1 mRNA and enzyme activity is inevitably lost. Importantly, reduced renal Dnase1 activity manifests itself at the same time fragmentation of chromatin in kidneys is reduced. The reason for the loss of renal Dnase1 is uncertain, and may involve different processes. Alteration of the Dnase1 promoter (promoter methylation, [44]), and the effect of regulatory RNA (like microRNA, [45]) are likely and testable processes. Of particular interest, however, is the fact that the hsp90-related protein Trap1 is encoded the opposite direction of Dnase1, and uses down-stream sequence elements of the Dnase1 gene (see ). This means that the two genes may not be transcribed at the same time, and therefore, they may mutually exclude each other. Trap1 is up-regulated during stress and has the function of a survival protein [46], [47]. Thus, Dnase1, as a death-associated protein, and Trap1 have antagonistic effects, and possibly also antagonistic expression profiles. These aspects are currently under investigation in our laboratory.
###end p 59
###begin p 60
To understand how the Dnase1 gene is down-regulated in the kidney may bring us a significant step towards the understanding of the molecular and genetical events that in the end result in progressive lupus nephritis. This insight is decisive to create a basis for development of new causal therapy modalities.
###end p 60
###begin title 61
Materials and Methods
###end title 61
###begin title 62
Ethics Statement
###end title 62
###begin p 63
The National Animal Research Authority (NARA) approved the study. Treatment and care of animals were conducted in accordance with guidelines of the Norwegian Ethical and Welfare Board for Animal Research.
###end p 63
###begin title 64
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine Tissue Samples
###end title 64
###begin p 65
###xml 448 452 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Tokuyasu1">[48]</xref>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
Renal tissue was collected from female (NZBxNZW)F1 (BW) and female age-matched BALB/c mice (Jackson Laboratory, Bar Harbor, Maine, USA) sacrificed approximately every second week (n = 3) from the age of 4 weeks until development of end-stage disease in the BW mice, clinically defined when severe proteinuria developed (>/=20 g/L). Tissue was either snapfrozen for protein extraction, preserved according to Tokuyasu for immune electron microscopy [48], or preserved in RNAlater (Ambion Inc., Texas, USA) for mRNA analyses. Serum and urine samples were collected at 2-3 week intervalls and stored at -80degreesC.
###end p 65
###begin title 66
Determination of Proteinuria
###end title 66
###begin p 67
Proteinuria was determined by urine stix (Bayer Diagnostics, Bridgend, United Kingdom): 0-1+ (</=0.3 g/L, regarded as physiological proteinuria); 2+, (</=1 g/L); 3+, (</=3 g/L); and 4+, (>/=20 g/L).
###end p 67
###begin title 68
Anti-dsDNA Antibody ELISA
###end title 68
###begin p 69
###xml 79 83 79 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Haugbro1">[32]</xref>
###xml 85 89 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Rekvig2">[49]</xref>
###xml 170 174 <span type="species:ncbi:9913">calf</span>
Serum anti-dsDNA antibodies were detected and controlled by ELISA as described [32], [49], using microtiter plates (Nunc MaxiSorp; Nunc, Copenhagen, Denmark) coated with calf thymus dsDNA (10 microg/ml in PBS, Sigma-Aldrich, Saint Louis, USA).
###end p 69
###begin title 70
Immune Electron Microscopy (IEM)
###end title 70
###begin p 71
###xml 186 190 186 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Tokuyasu1">[48]</xref>
###xml 243 247 243 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Kalaaji2">[12]</xref>
For immune electron microscopy, kidney samples were fixed in 8% formaldehyde in PBS, further processed in sucrose and glycine before mounted and immersed in liquid nitrogen as described [48]. Ultrathin cryosections were processed as described [12] to correlate the morphological changes with the presence of autoantibodies bound in the glomeruli in vivo. The grids were contrasted with uranyl acetate and examined at x20-x40 K magnification using a JEM-1010 transmission electron microscope (Jeol, Tokyo, Japan).
###end p 71
###begin title 72
Purification of Renal RNA and cDNA Synthesis
###end title 72
###begin p 73
###xml 193 201 193 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008474.s001">Table S1</xref>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
Total RNA was isolated from RNAlater-preserved kidneys using EZ-1 RNA tissue mini kit (Qiagen, Nordic, Norway). The kidneys were taken from all mice included in this study. These are listed in Table S1. The concentration of extracted RNA was determined by spectrophotometry using NanoDrop (NanoDrop technologies, Wilmington, USA), and quality was assessed using Agilent Bioanalyzer (Agilent Technologies, Santa Clara, USA). Samples were reverse-transcribed with random primers using High Capacity cDNA Reverse Transcription kit (Applied Biosystems, Foster City, USA).
###end p 73
###begin title 74
Real-Time PCR Analysis
###end title 74
###begin p 75
###xml 171 176 <span type="species:ncbi:10090">Mouse</span>
###xml 475 479 <span type="species:ncbi:10090">mice</span>
For real time PCR we used TaqMan(R) Gene Expression Assays (Applied Biosystems, CA, USA): Dnase1 Mm01342389_g1; MMP2 Mm00439508_m1; MMP9 Mm00442991_m1; endogenous control-Mouse ACTB (actin, beta) 4352933E and TATA binding protein Mm00446973_m1. The assays were performed on ABI Prism 7900HT Sequence Detection System (Applied Biosystems). Expression levels were calculated using the DeltaDeltaCT method. Data are given as fold change compared to transcription in 4 weeks old mice.
###end p 75
###begin title 76
Purification of Renal Proteins
###end title 76
###begin p 77
###xml 58 62 58 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Woessner1">[50]</xref>
###xml 93 97 93 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Tveita1">[28]</xref>
Proteins were purified from kidneys according to Woessner [50] as described by Tveita et al. [28]. Briefly, snapfrozen cortical tissue was homogenized in Tris buffer (0.5 mol/l Tris-HCl, pH 7.5, 150 mmol/l NaCl). The mixture was centrifuged and the supernatants were collected. The pellets were resuspended in heat extraction buffer (50 mM Tris pH 7.5, 0.1 M CaCl2, 0.15 M NaCl), incubated for 4 min at 60degreesC, and centrifuged. The supernatants were combined, and protein content was determined using BCA assay kit (Pierce Biochemicals, IL, USA). These preparations were used for Dnase1, MMP2 and MMP9 gel zymography.
###end p 77
###begin title 78
Dnase1 and MMP Gel Zymography
###end title 78
###begin p 79
###xml 218 222 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Rosenthal1">[51]</xref>
###xml 293 297 289 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008474-Tveita2">[29]</xref>
###xml 616 617 606 607 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 954 960 <span type="species:ncbi:9986">rabbit</span>
DNA degrading activity by Dnase1 was determined after separation of renal proteins in a 10% SDS-polyacrylamide gel containing 100 microg/ml heat-denatured salmon sperm DNA (Invitrogen Corp., Carlsbad, CA) as described [51]. MMP2 and MMP9 zymography was performed as described by Tveita et al. [29], as follows. After protein purification, proteins were separated on 7.5% SDS-PAGE gels containing gelatin (1.0 mg/ml). Following electrophoresis, gels were washed for 1 h in 2% Triton X-100 in 50 mM Tris-HCl, pH 7.4, followed by incubation at 37degreesC for 20 h in activation buffer (50 mM Tris-HCl, pH 7.4, 5 mM CaCl2). Gels were stained with Coomassie Blue. Clear zones against the background demonstrated presence of protease activity, and MMP2 and MMP9 were detected by MW according to position of recombinant enzymes in the gel. An actin-specific Western blot was performed to ensure equal loading of the different renal protein preparations using a rabbit IgG anti-actin antibody (Sigma-Aldrich).
###end p 79
###begin title 80
Statistics
###end title 80
###begin p 81
###xml 324 331 324 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008474-t001">Table 1</xref>
###xml 534 542 534 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g006">Figure 6</xref>
Data are presented as mean with standard deviation (SD). An unpaired t-test was performed to test differences between each group and a one-way ANOVA was performed to compare all groups for each parameter; p<0.05 was considered significant. The rcor.test function from the R language ltm package was used to generate data in Table 1. All observations were included and Spearman was used for significance testing. A principal component analysis (PCA) was performed on the same set of data and a biplot drawn with the R biplot function (Figure 6).
###end p 81
###begin title 82
Supporting Information
###end title 82
###begin p 83
###xml 202 206 <span type="species:ncbi:10090">mice</span>
Summary of data on mRNA levels of Dnase1, MMP2, and MMP9, anti-dsDNA antibody titers, deposits of immune complexes in the mesangial matrix and GBM, and proteinuria linked to each individual (NZBxNZW)F1 mice which are identified by labels.
###end p 83
###begin p 84
(0.03 MB XLS)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin p 86
###xml 155 163 155 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008474.s001">Table S1</xref>
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
Dnase1 gel zymography is given for each (NZBxNZW)F1 and BALB/c mouse included in the study. This figure, combined with the Dnase1 mRNA levels presented in Table S1 demonstrate that levels of Dnase1 mRNA correspond with levels of Dnase1 enzyme activity.
###end p 86
###begin p 87
(1.99 MB TIF)
###end p 87
###begin p 88
Click here for additional data file.
###end p 88
###begin p 89
###xml 28 36 28 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g006">Figure 6</xref>
###xml 147 155 147 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008474.s001">Table S1</xref>
###xml 295 303 295 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g001">Figure 1</xref>
###xml 308 316 308 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008474-g002">Figure 2</xref>
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 346 350 <span type="species:ncbi:10090">mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
This figure is identical to Figure 6 in the manuscript, with the additional information that each mouse can be identified by the same labels as in Table S1. The result of the biplot demonstrates that groups emerging from this analysis perfectly correlated with the groups of BW mice as given in Figure 1 and Figure 2, defined as pre-nephritic BW mice (Group 1), BW mice with deposits of EDS in the mesangial matrix (Group 2) or with deposits in the GBM (Group 3).
###end p 89
###begin p 90
(0.11 MB TIF)
###end p 90
###begin p 91
Click here for additional data file.
###end p 91
###begin p 92
We thank Berit Tommeras for expert technical help.
###end p 92
###begin title 93
References
###end title 93
###begin article-title 94
The 1982 revised criteria for the classification of systemic lupus erythematosus.
###end article-title 94
###begin article-title 95
###xml 143 151 <span type="species:ncbi:9606">patients</span>
Anti-DNA antibodies cross-reacting with laminin inhibit trophoblast attachment and migration: implications for recurrent pregnancy loss in SLE patients.
###end article-title 95
###begin article-title 96
###xml 2 8 <span type="species:ncbi:10090">murine</span>
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
A murine nephritogenic monoclonal anti-DNA autoantibody binds directly to mouse laminin, the major non-collagenous protein component of the glomerular basement membrane.
###end article-title 96
###begin article-title 97
Treatment with a laminin-derived peptide suppresses lupus nephritis.
###end article-title 97
###begin article-title 98
Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry.
###end article-title 98
###begin article-title 99
Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies.
###end article-title 99
###begin article-title 100
Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis?
###end article-title 100
###begin article-title 101
###xml 53 58 <span type="species:ncbi:9606">human</span>
Different mechanisms by which anti-DNA MoAbs bind to human endothelial cells and glomerular mesangial cells.
###end article-title 101
###begin article-title 102
Autoantibodies against glomerular mesangial cells and their target antigens in lupus nephritis.
###end article-title 102
###begin article-title 103
###xml 112 118 <span type="species:ncbi:10090">murine</span>
Nucleosomes possess a high affinity for glomerular laminin and collagen IV and bind nephritogenic antibodies in murine lupus-like nephritis.
###end article-title 103
###begin article-title 104
###xml 95 100 <span type="species:ncbi:9606">human</span>
Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis.
###end article-title 104
###begin article-title 105
Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells.
###end article-title 105
###begin article-title 106
###xml 87 92 <span type="species:ncbi:9606">human</span>
###xml 97 103 <span type="species:ncbi:10090">murine</span>
Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis.
###end article-title 106
###begin article-title 107
###xml 105 109 <span type="species:ncbi:10090">mice</span>
Reduced fragmentation of apoptotic chromatin is associated with nephritis in lupus-prone (NZB x NZW)F(1) mice.
###end article-title 107
###begin article-title 108
###xml 15 21 <span type="species:ncbi:10090">murine</span>
Progression of murine lupus nephritis is linked to acquired renal Dnase1 deficiency and not to up-regulated apoptosis.
###end article-title 108
###begin article-title 109
Cisplatin nephrotoxicity is mediated by deoxyribonuclease I.
###end article-title 109
###begin article-title 110
The toll of too much TLR7.
###end article-title 110
###begin article-title 111
Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
###end article-title 111
###begin article-title 112
The CpG motif: implications for clinical immunology.
###end article-title 112
###begin article-title 113
Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors.
###end article-title 113
###begin article-title 114
###xml 120 126 <span type="species:ncbi:10090">murine</span>
Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.
###end article-title 114
###begin article-title 115
Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity.
###end article-title 115
###begin article-title 116
Toll-like receptor 9 dependent activation of MAPK and NF-kB is required for the CpG ODN-induced matrix metalloproteinase-9 expression.
###end article-title 116
###begin article-title 117
The CD28-B7 costimulatory pathway and its role in autoimmune disease.
###end article-title 117
###begin article-title 118
B7 costimulation and autoantigen specificity enable B cells to activate autoreactive T cells.
###end article-title 118
###begin article-title 119
Protease yoga: extreme flexibility of a matrix metalloproteinase.
###end article-title 119
###begin article-title 120
Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites.
###end article-title 120
###begin article-title 121
###xml 58 64 <span type="species:ncbi:10090">murine</span>
Increased glomerular matrix metalloproteinase activity in murine lupus nephritis.
###end article-title 121
###begin article-title 122
Glomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis.
###end article-title 122
###begin article-title 123
Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes.
###end article-title 123
###begin article-title 124
Lupus nephritis: the central role of nucleosomes revealed.
###end article-title 124
###begin article-title 125
###xml 82 90 <span type="species:ncbi:9606">patients</span>
Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity.
###end article-title 125
###begin article-title 126
Anti-double-stranded DNA antibodies, nucleosomes, and systemic lupus erythematosus: a time for new paradigms?
###end article-title 126
###begin article-title 127
Activation of toll-like receptor-9 induces matrix metalloproteinase-9 expression through Akt and tumor necrosis factor-alpha signaling.
###end article-title 127
###begin article-title 128
Differential Toll-like receptor-dependent collagenase expression in chondrocytes.
###end article-title 128
###begin article-title 129
Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
###end article-title 129
###begin article-title 130
Matrix metalloproteinases.
###end article-title 130
###begin article-title 131
Trashing the genome: the role of nucleases during apoptosis.
###end article-title 131
###begin article-title 132
Chromatin breakdown during necrosis by serum Dnase1 and the plasminogen system.
###end article-title 132
###begin article-title 133
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity.
###end article-title 133
###begin article-title 134
The key role of nucleosomes in lupus.
###end article-title 134
###begin article-title 135
###xml 70 76 <span type="species:ncbi:10090">murine</span>
Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolyssacharide administration.
###end article-title 135
###begin article-title 136
###xml 10 15 <span type="species:ncbi:9606">human</span>
Intrinsic human glomerular mesangial cells can express receptors for IgG complexes (hFc gamma RIII-A) and the associated Fc epsilon RI gamma-chain.
###end article-title 136
###begin article-title 137
###xml 79 84 <span type="species:ncbi:9606">human</span>
De novo methylation, long-term promoter silencing, methylation patterns in the human genome, and consequences of foreign DNA insertion.
###end article-title 137
###begin article-title 138
###xml 92 100 <span type="species:ncbi:9606">patients</span>
Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients.
###end article-title 138
###begin article-title 139
Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis.
###end article-title 139
###begin article-title 140
###xml 33 38 <span type="species:ncbi:9606">human</span>
The HSP90 family of genes in the human genome: insights into their divergence and evolution.
###end article-title 140
###begin article-title 141
Application of cryoultramicrotomy to immunocytochemistry.
###end article-title 141
###begin article-title 142
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 62 67 <span type="species:ncbi:9606">human</span>
Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-antigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors.
###end article-title 142
###begin article-title 143
Matrilysin.
###end article-title 143
###begin article-title 144
Nuclease detection in SDS-polyacrylamide gel electrophoresis.
###end article-title 144
###begin p 145
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 145
###begin p 146
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by Foundation for Health and Rehabilitation through the Norwegian Rheumatology Organization (project 2004/2/0250), from Northern Norway Regional Health Authority Medical Research Program (Grants # SFP-100-04, SFP-101-04, and Thematic Research Support), and from University of Tromso, as a Milieu support given to OPR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 146

